AU2020397173A1 - Use of a KV7 potassium channel opener for treating pain - Google Patents
Use of a KV7 potassium channel opener for treating pain Download PDFInfo
- Publication number
- AU2020397173A1 AU2020397173A1 AU2020397173A AU2020397173A AU2020397173A1 AU 2020397173 A1 AU2020397173 A1 AU 2020397173A1 AU 2020397173 A AU2020397173 A AU 2020397173A AU 2020397173 A AU2020397173 A AU 2020397173A AU 2020397173 A1 AU2020397173 A1 AU 2020397173A1
- Authority
- AU
- Australia
- Prior art keywords
- pain
- compound
- human
- dose
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Light Guides In General And Applications Therefor (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962945093P | 2019-12-06 | 2019-12-06 | |
US62/945,093 | 2019-12-06 | ||
US201962948010P | 2019-12-13 | 2019-12-13 | |
US62/948,010 | 2019-12-13 | ||
PCT/US2020/063471 WO2021113757A1 (en) | 2019-12-06 | 2020-12-04 | Use of a kv7 potassium channel opener for treating pain |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2020397173A1 true AU2020397173A1 (en) | 2022-06-23 |
Family
ID=73856375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020397173A Pending AU2020397173A1 (en) | 2019-12-06 | 2020-12-04 | Use of a KV7 potassium channel opener for treating pain |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP4069211A1 (ja) |
JP (1) | JP2023504166A (ja) |
KR (1) | KR20220113411A (ja) |
CN (1) | CN114786658A (ja) |
AU (1) | AU2020397173A1 (ja) |
BR (1) | BR112022010733A2 (ja) |
CA (1) | CA3159436A1 (ja) |
CL (1) | CL2022001477A1 (ja) |
CR (1) | CR20220318A (ja) |
IL (1) | IL293504A (ja) |
MX (1) | MX2022006877A (ja) |
PE (1) | PE20221169A1 (ja) |
TW (1) | TW202133847A (ja) |
WO (1) | WO2021113757A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113698345B (zh) * | 2021-10-27 | 2022-02-01 | 上海挚盟医药科技有限公司 | 作为钾通道调节剂的化合物及其制备和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8993593B2 (en) * | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
AU2007288253B2 (en) * | 2006-08-23 | 2013-05-02 | Xenon Pharmaceuticals Inc. | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
WO2013067591A1 (en) * | 2011-11-10 | 2013-05-16 | Relevare Australia Pty Ltd | Topical formulations for pain management |
US9248122B2 (en) * | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
KR20210020892A (ko) * | 2018-05-11 | 2021-02-24 | 제논 파마슈티칼스 인크. | 전압 의존형 칼륨 채널 개방제의 생체 이용률 및 노출을 향상시키는 방법 |
-
2020
- 2020-12-04 WO PCT/US2020/063471 patent/WO2021113757A1/en unknown
- 2020-12-04 IL IL293504A patent/IL293504A/en unknown
- 2020-12-04 CR CR20220318A patent/CR20220318A/es unknown
- 2020-12-04 KR KR1020227021509A patent/KR20220113411A/ko active Search and Examination
- 2020-12-04 JP JP2022532695A patent/JP2023504166A/ja active Pending
- 2020-12-04 TW TW109142937A patent/TW202133847A/zh unknown
- 2020-12-04 PE PE2022001015A patent/PE20221169A1/es unknown
- 2020-12-04 CN CN202080084722.3A patent/CN114786658A/zh active Pending
- 2020-12-04 CA CA3159436A patent/CA3159436A1/en active Pending
- 2020-12-04 AU AU2020397173A patent/AU2020397173A1/en active Pending
- 2020-12-04 EP EP20828491.9A patent/EP4069211A1/en active Pending
- 2020-12-04 MX MX2022006877A patent/MX2022006877A/es unknown
- 2020-12-04 BR BR112022010733A patent/BR112022010733A2/pt unknown
-
2022
- 2022-06-03 CL CL2022001477A patent/CL2022001477A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2023504166A (ja) | 2023-02-01 |
CN114786658A (zh) | 2022-07-22 |
CR20220318A (es) | 2022-10-07 |
EP4069211A1 (en) | 2022-10-12 |
BR112022010733A2 (pt) | 2022-08-23 |
PE20221169A1 (es) | 2022-07-25 |
TW202133847A (zh) | 2021-09-16 |
MX2022006877A (es) | 2022-07-11 |
CA3159436A1 (en) | 2021-06-10 |
KR20220113411A (ko) | 2022-08-12 |
IL293504A (en) | 2022-08-01 |
WO2021113757A1 (en) | 2021-06-10 |
CL2022001477A1 (es) | 2023-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200345718A1 (en) | Morphinan Derivatives for the Treatment of Drug Overdose | |
US6248789B1 (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
US5543434A (en) | Nasal administration of ketamine to manage pain | |
TW200418474A (en) | Method of treating post-operative nausea and vomiting | |
WO2009145289A1 (ja) | 鎮痛耐性抑制剤 | |
CA2230690C (en) | Administration of ketamine to manage pain and to reduce drug dependency | |
US20170273925A1 (en) | Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain | |
CA2688542C (en) | Methods and compositions for administration of oxybutynin | |
JP2017506244A (ja) | ノルイボガイン及び関連化合物を用いた治療方法 | |
US20210213009A1 (en) | Methods of treating pain | |
AU2020397173A1 (en) | Use of a KV7 potassium channel opener for treating pain | |
JPS62298530A (ja) | 坐薬用医薬組成物 | |
US20080132531A1 (en) | Synergistic combinations of norketamine and opioid analgesics | |
NO309965B1 (no) | Oralt farmasøytisk antihostepreparat | |
US20120059024A1 (en) | Drug abuse deterrent, methods and compositions | |
US10736874B1 (en) | Methods for treating pain associated with sickle cell disease | |
KR20040020054A (ko) | 통증 치료시 중독 예방 | |
EP1734940B1 (en) | Combinations of deramciclane and opioids for use as analgesics | |
US20220233492A1 (en) | Method of preventing or treating postoperative pain | |
AU2004233582B2 (en) | Pharmaceutical compositon comprising a cathepsin S inhibitor and an opioid | |
EP1797883A2 (en) | Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid | |
US20090281194A1 (en) | Combinations for treating HIV-associated pain |